The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwNHL 2018 | Viral lymphomas: risk factors and treatments
Viruses such Epstein-Barr virus (EBV) and HIV have been aetiologically linked to a significant number of lymphoproliferative diseases. In this roundtable discussion, lead by Catherine Bollard, MBChB, MD, FRACP, FRCPA, of the Children’s National Health System, Washington, DC, Dr Bollard covers the risk factors for viral lymphomas, as well as the current landscape for therapy and trial participation. She is joined by Ruth Jarrett, MD, PhD, from the University of Glasgow Center for Virus Research, Glasgow, UK, Mark Roschewski, MD, of the National Cancer Institute, Bethesda, MD, and Richard Little, MD, of the National Cancer Institute, Rockville, MD, at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France.
